Patents by Inventor Lev Tsimring

Lev Tsimring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230126966
    Abstract: Provided are bacterial strains, methods of culturing bacterial cells using synthetic quorum-regulated lysis, and uses thereof.
    Type: Application
    Filed: November 30, 2022
    Publication date: April 27, 2023
    Inventors: Jeff Hasty, Lev Tsimring, Spencer R. Scott, Muhammad Omar Din
  • Patent number: 11613758
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: March 28, 2023
    Assignees: The Regents of the University of California, Massachusetts Institute of Technology
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Publication number: 20220251579
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Application
    Filed: November 11, 2021
    Publication date: August 11, 2022
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Publication number: 20220057378
    Abstract: Provided are a microfluidic biosensors that are suitable for continuously monitoring toxin levels in water supplies.
    Type: Application
    Filed: September 2, 2021
    Publication date: February 24, 2022
    Inventors: Jeff Hasty, Leo Alexander Baumgart, Scott Cookson, Michael Ferry, Garrett Graham, Ramon Huerta, Ryan Johnson, Lev Tsimring
  • Patent number: 11209412
    Abstract: Provided are a microfluidic biosensors that are suitable for continuously monitoring toxin levels in water supplies.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: December 28, 2021
    Assignee: The Regents of the University of California
    Inventors: Jeff Hasty, Leo Alexander Baumgart, Scott Cookson, Michael Ferry, Garrett Graham, Ramon Huerta, Ryan Johnson, Lev Tsimring
  • Patent number: 11174486
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: November 16, 2021
    Assignees: The Regents of the University of California, Massachusetts Institute of Technology
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Publication number: 20210284953
    Abstract: Provided are bacterial strains, methods of culturing bacterial cells using synthetic quorum-regulated lysis, and uses thereof.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 16, 2021
    Inventors: Jeff Hasty, Lev Tsimring, Spencer R. Scott, Muhammad Omar Din
  • Publication number: 20180149633
    Abstract: Provided are a microfluidic biosensors that are suitable for continuously monitoring toxin levels in water supplies.
    Type: Application
    Filed: February 12, 2016
    Publication date: May 31, 2018
    Inventors: Jeff Hasty, Leo Alexander Baumgart, Scott Cookson, Michael Ferry, Garrett Graham, Ramon Huerta, Ryan Johnson, Lev Tsimring
  • Publication number: 20180148729
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Application
    Filed: April 7, 2016
    Publication date: May 31, 2018
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino